Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Neurology, Neurosurgery, and Psychiatry 2004;75:962-965; doi:10.1136/jnnp.2003.026203
Copyright © 2004 by the BMJ Publishing Group Ltd.
Journal of Neurology Neurosurgery and Psychiatry 2004;75:962-965
© 2004 BMJ Publishing Group Ltd

PAPER

Tau gene and Parkinson’s disease: a case–control study and meta-analysis

D G Healy1, P M Abou-Sleiman1, A J Lees1,3, J P Casas4, N Quinn2, K Bhatia2, A D Hingorani4 and N W Wood1

1 Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London, UK
2 Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square
3 Reta LilaWeston Institute for Neurological Studies, University of London
4 Centre for Clinical Pharmacology, BHF Laboratories at UCL, London

Correspondence to:
Correspondence to:
Dr Daniel G Healy
Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London WC1N 3BG, UK; n.wood{at}ion.ucl.ac.uk

Objective: To investigate whether the tau H1 haplotype is a genetic risk factor in Parkinson’s disease and to report a meta-analysis on all previously published data

Methods and results: In a sample of 580 patients with Parkinson’s disease and 513 controls there was an increased risk of Parkinson’s disease for both the tau H1 haplotype (p<=0.0064; odds ratio (OR) 1.34 (95% confidence interval (CI), 1.04 to 1.72)) and the H1H1 genotype (p<=0.0047; OR 1.42 (1.1 to 1.83)). Under a fixed effect model, the summary OR for this showed that individuals homozygous for the H1 allele were 1.57 times more likely to develop Parkinson’s disease than individuals carrying the H2 allele (95% CI 1.33 to 1.85; p<0.00001). The population attributable risk for the tau variant, for the main comparison of H1H1 against H2 carriers, was 24.8% for all studies combined.

Conclusions: Homozygosity for the tau H1 is associated with an increased risk of Parkinson’s disease. This adds to the growing body of evidence that common genetic variation contributes to the pathogenesis of this disorder.

Abbreviations: FPD, familial Parkinson’s disease; LD, linkage disequilibrium; PSP, progressive supranuclear palsy; YOPD, young onset Parkinson’s disease

Keywords: Parkinson’s disease; H1 haplotype; meta-analysis


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Pittman, A. M., Fung, H.-C., de Silva, R. (2006). Untangling the tau gene association with neurodegenerative disorders. Hum Mol Genet 15: R188-R195 [Abstract] [Full Text]  
  • Pittman, A M, Myers, A J, Abou-Sleiman, P, Fung, H C, Kaleem, M, Marlowe, L, Duckworth, J, Leung, D, Williams, D, Kilford, L, Thomas, N, Morris, C M, Dickson, D, Wood, N W, Hardy, J, Lees, A J, de Silva, R (2005). Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J. Med. Genet. 42: 837-846 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest neurology and neurosurgery jobs

Neurology and neurosurgery jobs